5. References
- Clinical Pharmacology [database online]. Tampa, FL: Gold Standard, Inc; 2024. Available at: http://www.clinicalpharmacology.com. Accessed June 7, 2024.
- Cytomegalovirus immune globulin intravenous – human (Cytogam) package insert. Kamada, LTD. February 2023.
- Immune globulin intravenous 5% - human (Flebogamma 5% DIF) package insert. Grifols, November 2019.
- Immune globulin intravenous 10% - human (Flebogamma 10% DIF) package insert. Grifols, November 2019.
- Immune globulin infusion 10% solution – human (Gammagard Liquid) package insert. Takeda Pharmaceuticals America, Inc. January 2024.
- Immune globulin injection 10% - human (Gammaked) package insert. Kedrion Biopharma, Inc. January 2020.
- Immune globulin injection – human (Gamunex-C) package insert. Grifols Therapeutics Inc., April 2022.
- Immune globulin intravenous 5% - human (Octagam 5%) package insert. Octapharma USA Inc., April 2022.
- Immune globulin intravenous 10% - human (Octagam 10%) package insert. Octapharma USA Inc., April 2022.
- Immune globulin intravenous 10% liquid – human (Privigen) package insert. CSL Behring LLC, April 2022.
- Immune globulin subcutaneous- human-hipp (Cutaquig) package insert. Octapharma USA Inc., November 2021.
- Immune globulin subcutaneous – human (Cuvitru) package insert. Takeda Pharmaceuticals America, Inc. March 2023.
- Immune globulin subcutaneous – human (Hizentra) package insert. CSL Behring LLC. April 2023.
- Immune globulin infusion 10% - human, with recombinant human hyaluronidase (Hyqvia) package insert. Takeda Pharmaceuticals America, Inc. January 2024.
- Immune globulin subcutaneous- human-klhw (Xembify) package insert. Grifols Therapeutics Inc., February 2022.